According to the results of a study published in Pediatrics, paternal selective serotonin reuptake inhibitor (SSRI) use was associated with a mildly increased risk for attention-deficit/hyperactivity disorder (ADHD) in offspring, regardless of whether SSRI use was 12 to 3 months before conception or during the 3 months before conception. The researchers hypothesize that this increased risk may be caused by underlying indications related to SSRI use.